Patent · US Active

Methods and compositions for detecting mutation in the human EZH2 gene

US10260102B2 · kind B2 · utility

0Cited by

0References

12Claims

0Family size

Assignee

Roche Molecular Systems, Inc. · US

Inventors

Xiaoju Max Ma · San Carlos, US
Chitra Manohar · San Ramon, US
Alison Tsan · Castro Valley, US

Key dates

Filing date	Oct 7, 2014
Grant date	Apr 16, 2019
Priority date	—
Expiry date	Jul 15, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention comprises reagents and methods for detecting cancer-associated mutations in the human EZH2 gene. Further, a method of detecting the mutations and a method of treatment are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.